[HTML][HTML] Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 …

…, L Goldstein, EA Perez, LN Shulman… - Journal of clinical …, 2014 - ncbi.nlm.nih.gov
Purpose Recent studies suggest that tumor-infiltrating lymphocytes (TILs) are associated
with disease-free (DFS) and overall survival (OS) in operable triple-negative breast cancer (…

Expansion of cancer care and control in countries of low and middle income: a call to action

P Farmer, J Frenk, FM Knaul, LN Shulman, G Alleyne… - The Lancet, 2010 - thelancet.com
Substantial inequalities exist in cancer survival rates across countries. In addition to
prevention of new cancers by reduction of risk factors, strategies are needed to close the gap …

Using the National Cancer Database for outcomes research: a review

…, K Thoburn, D Gress, DP McKellar, LN Shulman… - JAMA …, 2017 - jamanetwork.com
Importance The National Cancer Database (NCDB), a joint quality improvement initiative of
the American College of Surgeons Commission on Cancer and the American Cancer Society…

[HTML][HTML] The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer

…, B Silver, DF Hayes, LN Shulman… - … England Journal of …, 1996 - Mass Medical Soc
Background Patients with early-stage breast cancer who are at substantial risk for systemic
metastases are increasingly treated with breast-conserving therapy and adjuvant …

Breast cancer in developing countries: opportunities for improved survival

LN Shulman, W Willett, A Sievers… - Journal of …, 2010 - Wiley Online Library
Breast cancer survival in the USA has continually improved over the last six decades and
has largely been accredited to the use of mammography, advanced surgical procedures, and …

Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer

…, PG Richardson, K Clarke, LN Shulman… - Journal of Clinical …, 2001 - ascopubs.org
PURPOSE: To determine the response rate and toxicity profile of trastuzumab administered
concurrently with weekly vinorelbine in women with HER2-overexpressing advanced breast …

[HTML][HTML] Prognostic utility of the 21-gene assay in hormone receptor–positive operable breast cancer compared with classical clinicopathologic features

…, GW Sledge Jr, EA Perez, LN Shulman… - Journal of Clinical …, 2008 - ncbi.nlm.nih.gov
Purpose Adjuvant! is a standardized validated decision aid that projects outcomes in
operable breast cancer based on classical clinicopathologic features and therapy. Genomic …

[HTML][HTML] Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer …

…, SK Boolbol, BO Anderson, LN Shulman… - Breast cancer research …, 2020 - Springer
The COVID-19 pandemic presents clinicians a unique set of challenges in managing breast
cancer (BC) patients. As hospital resources and staff become more limited during the COVID…

Medical imaging and nuclear medicine: a Lancet Oncology Commission

…, JS Lewis, G McGinty, WJG Oyen, LN Shulman… - The Lancet …, 2021 - thelancet.com
The diagnosis and treatment of patients with cancer requires access to imaging to ensure
accurate management decisions and optimal outcomes. Our global assessment of imaging …

Docetaxel administered on a weekly basis for metastatic breast cancer

…, JE Garber, KD Clarke, LN Shulman… - Journal of Clinical …, 2000 - ascopubs.org
PURPOSE: To evaluate the safety and efficacy of weekly docetaxel in women with metastatic
breast cancer. PATIENTS AND METHODS: Twenty-nine women were enrolled onto a study …